Biotinidase deficiency: Novel mutations in Algerian patients

Biotinidase deficiency is an autosomal recessive disorder of biotin metabolism leading to varying degrees of neurologic and cutaneous symptoms when untreated. In the present study, we report the clinical features and the molecular investigation of biotinidase deficiency in four unrelated consanguine...

Full description

Saved in:
Bibliographic Details
Published inGene Vol. 536; no. 1; pp. 193 - 196
Main Authors Tiar, A., Mekki, A., Nagara, M., Rhouma, F. Ben, Messaoud, O., Halim, N. Ben, Kefi, R., Hamlaoui, M.T., Lebied, A., Abdelhak, S.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.02.2014
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Biotinidase deficiency is an autosomal recessive disorder of biotin metabolism leading to varying degrees of neurologic and cutaneous symptoms when untreated. In the present study, we report the clinical features and the molecular investigation of biotinidase deficiency in four unrelated consanguineous Algerian families including five patients with profound biotinidase deficiency and one child characterized as partial biotinidase deficiency. Mutation analysis revealed three novel mutations, c.del631C and c.1557T>G within exon 4 and c.324-325insTA in exon 3. Since newborn screening is not available in Algeria, cascade screening in affected families would be very helpful to identify at risk individuals. ► This is the first study on clinical and molecular investigation of BD in Algeria. ► Three novel mutations were identified: c.631delC, c.1557T>G and c.324-325insTA. ► As newborn screening is not available, cascade genetic screening could be performed.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0378-1119
1879-0038
DOI:10.1016/j.gene.2013.02.011